News

Megan Clowse, MD, MPH, is excited about a new development in the Duke Lupus Clinic that has opened up new ways of understanding, treating, and talking about lupus.

For women who take hydroxychloroquine (HCQ) to control rheumatic disease, research has shown that it’s best for mother and baby to continue the medicine during pregnancy. But should the dose be maintained, decreased, or increased? Stephen Balevic, MD, assistant professor of pediatrics and medicine (Rheumatology and Immunology), set out to investigate this question using data from the Duke Autoimmunity in Pregnancy registry. 

The following faculty received funding awards in March 2019.

The Department of Medicine has awarded the 2019 Chair's Research Award to four junior investigators who are making the transition to becoming independent scientists prior to their acquisition of extramural funding.

Two Department Medicine faculty members were inducted into the Association of American Physicians (AAP) during a joint April 6 meeting of the AAP, the Ame

Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for April 8, 2019.

Kathleen Cooney, MD, chair of the Department of Medicine, announced that Andrew Alspaugh, MD, will serve as Vice Chair for Academic Affairs in the Department of Medicine, and David Pisetsky, MD, PhD, has agreed to serve as Associate Vice Chair for Academic Affairs, effective April 1.

Gregory Gray, MD, MPH, professor of medicine (Infectious Diseases), global health and in the Nicholas School of the Environment, will present his research at the Department's Research Seminar Series on Friday, April 26, 2019 at 12 p.m. in Duke Hospital Room 2002.

This past week was the 17th year for Duke Teaching and Leading EBM, a workshop for educators and champions from across the count

Gentzon Hall, MD, PhD, assistant professor of medicine (Nephrology), is passionate about a specialty area of research that is often overlooked by potential funders - the genetically targeted treatment of Familial Nephrotic Syndrome. “This disease doesn’t have many treatments, especially not that are targeted. The few that are targeted have ill-defined effects with general guidelines,” Dr. Hall said. The uncharted territory of this research area left him in a familiar conundrum for many investigators: pursue his passion in an uphill battle or give it up in favor of a more fundable concept.